CLIC2
gene geneOn this page
Also known as XAP121CLCNL2
Summary
CLIC2 (CLIC family member 2, HGNC:2063) is a protein-coding gene on chromosome Xq28, encoding Chloride intracellular channel protein 2 (O15247). In the soluble state, catalyzes glutaredoxin-like thiol disulfide exchange reactions with reduced glutathione as electron donor.
This gene encodes a chloride intracellular channel protein. Chloride channels are a diverse group of proteins that regulate fundamental cellular processes including stabilization of cell membrane potential, transepithelial transport, maintenance of intracellular pH, and regulation of cell volume. This protein plays a role in inhibiting the function of ryanodine receptor 2. A mutation in this gene is the cause of an X-linked form of cognitive disability.
Source: NCBI Gene 1193 — RefSeq curated summary.
At a glance
- Gene–disease (curated): X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome (Moderate, GenCC) — +1 more curated relationship
- Clinical variants (ClinVar): 95 total — 1 likely-pathogenic
- Phenotypes (HPO): 30
- MANE Select transcript:
NM_001289
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:2063 |
| Approved symbol | CLIC2 |
| Name | CLIC family member 2 |
| Location | Xq28 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | XAP121, CLCNL2 |
| Ensembl gene | ENSG00000155962 |
| Ensembl biotype | protein_coding |
| OMIM | 300138 |
| Entrez | 1193 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 3 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000321926, ENST00000369449, ENST00000465553, ENST00000491205, ENST00000948941
RefSeq mRNA: 1 — MANE Select: NM_001289
NM_001289
CCDS: CCDS14767
Canonical transcript exons
ENST00000369449 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001847718 | 155276211 | 155278064 |
| ENSE00001890277 | 155334371 | 155334614 |
| ENSE00003459873 | 155279962 | 155280068 |
| ENSE00003518869 | 155298785 | 155298910 |
| ENSE00003545471 | 155299036 | 155299145 |
| ENSE00003567274 | 155279149 | 155279330 |
Expression profiles
Bgee: expression breadth ubiquitous, 232 present calls, max score 93.46.
FANTOM5 (CAGE): breadth broad, TPM avg 7.9582 / max 541.5667, expressed in 688 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 201086 | 5.1044 | 630 |
| 201084 | 2.7854 | 451 |
| 201085 | 0.0684 | 27 |
Top tissues by expression
283 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 93.46 | gold quality |
| colonic epithelium | UBERON:0000397 | 90.39 | gold quality |
| right lung | UBERON:0002167 | 90.03 | gold quality |
| spleen | UBERON:0002106 | 89.22 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 89.22 | gold quality |
| gall bladder | UBERON:0002110 | 89.17 | gold quality |
| superficial temporal artery | UBERON:0001614 | 89.14 | gold quality |
| upper lobe of lung | UBERON:0008948 | 89.08 | gold quality |
| lymph node | UBERON:0000029 | 89.05 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 88.94 | gold quality |
| thyroid gland | UBERON:0002046 | 88.62 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 88.43 | gold quality |
| omental fat pad | UBERON:0010414 | 87.69 | gold quality |
| peritoneum | UBERON:0002358 | 87.62 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 86.87 | gold quality |
| lung | UBERON:0002048 | 86.78 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 86.74 | gold quality |
| lower lobe of lung | UBERON:0008949 | 86.72 | gold quality |
| tendon | UBERON:0000043 | 84.98 | gold quality |
| rectum | UBERON:0001052 | 84.93 | gold quality |
| vermiform appendix | UBERON:0001154 | 84.78 | gold quality |
| skin of hip | UBERON:0001554 | 84.70 | gold quality |
| pericardium | UBERON:0002407 | 84.59 | gold quality |
| endocervix | UBERON:0000458 | 83.68 | gold quality |
| adipose tissue | UBERON:0001013 | 83.64 | gold quality |
| connective tissue | UBERON:0002384 | 83.40 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 83.35 | gold quality |
| body of uterus | UBERON:0009853 | 83.10 | gold quality |
| left ovary | UBERON:0002119 | 82.87 | gold quality |
| mucosa of stomach | UBERON:0001199 | 82.52 | gold quality |
Single-cell (SCXA)
Detected in 8 experiment(s), a significant marker in 8.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-86618 | yes | 404.20 |
| E-MTAB-8142 | yes | 120.22 |
| E-HCAD-11 | yes | 38.12 |
| E-ANND-3 | yes | 22.63 |
| E-MTAB-8498 | yes | 10.12 |
| E-GEOD-135922 | yes | 9.68 |
| E-MTAB-6678 | yes | 7.26 |
| E-MTAB-5061 | yes | 6.40 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1, ZNF804A
miRNA regulators (miRDB)
76 targeting CLIC2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-LET-7A-2-3P | 99.87 | 70.53 | 1921 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-221-3P | 99.86 | 71.56 | 1329 |
| HSA-MIR-222-3P | 99.86 | 71.35 | 1337 |
| HSA-MIR-5003-3P | 99.85 | 69.29 | 2517 |
| HSA-LET-7G-3P | 99.85 | 70.43 | 1929 |
| HSA-MIR-576-5P | 99.84 | 70.46 | 2582 |
Literature-anchored findings (GeneRIF, showing 7)
- CLIC2 inhibited cardiac ryanodine receptor Ca2+ release channels in lipid bilayers when added to the cytoplasmic side of the channels and inhibited Ca2+ release from cardiac sarcoplasmic reticulum vesicles (PMID:15147738)
- CLIC2 forms pH-dependent chloride channels in vitro with higher channel activity at low pH levels and that the channels are subject to redox regulation (PMID:17945253)
- Human CLIC2 was crystallized in 2 different forms, in presence of GSSH. Form A displayed P2(1)2(1)2(1) symmetry, with unit-cell parameters a=44.0, b=74.7, c=79.8 A. Form B displayed P2(1) symmetry, with unit-cell parameters a=36.0, b=66.9, c=44.1 A. (PMID:18007051)
- crystal structure of soluble human CICL2 and implications for function (PMID:18186468)
- a vital role for the CLIC2 protein in maintaining normal cognitive function via its interaction with RyRs in the brain. (PMID:22814392)
- We have determined the crystal structure of soluble Clic2 from the euryhaline teleost fish Oreochromis mossambicus. Structural comparison of tilapia and human CLIC2 with other CLICs shows that these proteins are highly conserved. (PMID:29198705)
- Chloride intracellular channel protein 2 is secreted and inhibits MMP14 activity, while preventing tumor cell invasion and metastasis. (PMID:34229297)
Cross-species orthologs
33 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | clic2 | ENSDARG00000010625 |
| rattus_norvegicus | Clic2 | ENSRNOG00000000728 |
| drosophila_melanogaster | GstD1 | FBGN0001149 |
| drosophila_melanogaster | GstD2 | FBGN0010038 |
| drosophila_melanogaster | GstD3 | FBGN0010039 |
| drosophila_melanogaster | GstD4 | FBGN0010040 |
| drosophila_melanogaster | GstD5 | FBGN0010041 |
| drosophila_melanogaster | GstD6 | FBGN0010042 |
| drosophila_melanogaster | GstD7 | FBGN0010043 |
| drosophila_melanogaster | GstD8 | FBGN0010044 |
| drosophila_melanogaster | GstE12 | FBGN0027590 |
| drosophila_melanogaster | Clic | FBGN0030529 |
| drosophila_melanogaster | GstT3 | FBGN0031117 |
| drosophila_melanogaster | GstE13 | FBGN0033381 |
| drosophila_melanogaster | GstE1 | FBGN0034335 |
| drosophila_melanogaster | GstE11 | FBGN0034354 |
| drosophila_melanogaster | GstD9 | FBGN0038020 |
| drosophila_melanogaster | GstD10 | FBGN0042206 |
| drosophila_melanogaster | GstT1 | FBGN0050000 |
| drosophila_melanogaster | GstT2 | FBGN0050005 |
| drosophila_melanogaster | GstE9 | FBGN0063491 |
| drosophila_melanogaster | GstE8 | FBGN0063492 |
| drosophila_melanogaster | GstE7 | FBGN0063493 |
| drosophila_melanogaster | GstE6 | FBGN0063494 |
| drosophila_melanogaster | GstE5 | FBGN0063495 |
| drosophila_melanogaster | GstE4 | FBGN0063496 |
| drosophila_melanogaster | GstE3 | FBGN0063497 |
| drosophila_melanogaster | GstE2 | FBGN0063498 |
| drosophila_melanogaster | GstE10 | FBGN0063499 |
| caenorhabditis_elegans | exc-4 | WBGENE00001365 |
| caenorhabditis_elegans | WBGENE00001371 | |
| caenorhabditis_elegans | gst-43 | WBGENE00001791 |
| caenorhabditis_elegans | WBGENE00021817 |
Paralogs (14): GSTO2 (ENSG00000065621), GSTT2 (ENSG00000099984), GSTZ1 (ENSG00000100577), GDAP1 (ENSG00000104381), CLIC5 (ENSG00000112782), GDAP1L1 (ENSG00000124194), GSTT2B (ENSG00000133433), GSTO1 (ENSG00000148834), CLIC6 (ENSG00000159212), CLIC4 (ENSG00000169504), CLIC3 (ENSG00000169583), CLIC1 (ENSG00000213719), EEF1G (ENSG00000254772), GSTT4 (ENSG00000276950)
Protein
Protein identifiers
Chloride intracellular channel protein 2 — O15247 (reviewed: O15247)
Alternative names: Glutaredoxin-like oxidoreductase CLIC2, Glutaredoxin-like peroxidase CLIC2, XAP121
All UniProt accessions (2): O15247, A6PVS0
UniProt curated annotations — full annotation on UniProt →
Function. In the soluble state, catalyzes glutaredoxin-like thiol disulfide exchange reactions with reduced glutathione as electron donor. Displays weak glutathione peroxidase activity. Can insert into membranes and form chloride ion channels. Membrane insertion seems to be redox-regulated and may occur only under oxidizing conditions. Modulates the activity of RYR2 and inhibits calcium influx.
Subunit / interactions. Monomer. Interacts with TRAPPC2 and RYR2.
Subcellular location. Cytoplasm. Membrane.
Tissue specificity. Expressed in adult and fetal brain, heart, skeletal muscle, liver, lung, and spleen. Detected in adult stomach and testis. Expressed in fetal thymus and kidney.
Activity regulation. The channel conductance is regulated by pH.
Domain organisation. Members of this family may change from a globular, soluble state to a state where the N-terminal domain is inserted into the membrane and functions as a chloride channel. The redox status of the active cysteine in Cys-X-X-Cys motif likely determines the capacity to adopt a soluble or membrane-inserted state. A conformation change of the N-terminal domain is thought to expose hydrophobic surfaces that trigger membrane insertion. The active G-site has a dithiol Cys-X-X-Cys motif which mediates glutathione-dependent redox catalysis.
Similarity. Belongs to the chloride channel CLIC family.
RefSeq proteins (1): NP_001280* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002946 | CLIC | Family |
| IPR010987 | Glutathione-S-Trfase_C-like | Domain |
| IPR030253 | GST_C_CLIC-2 | Domain |
| IPR036249 | Thioredoxin-like_sf | Homologous_superfamily |
| IPR036282 | Glutathione-S-Trfase_C_sf | Homologous_superfamily |
| IPR040079 | Glutathione_S-Trfase | Family |
| IPR053823 | CLIC_N | Domain |
Pfam: PF13410, PF22441
Catalyzed reactions (Rhea), 3 shown:
- chloride(in) = chloride(out) (RHEA:29823)
- tert-butyl hydroperoxide + 2 glutathione = tert-butanol + glutathione disulfide + H2O (RHEA:69412)
- cumene hydroperoxide + 2 glutathione = 2-phenylpropan-2-ol + glutathione disulfide + H2O (RHEA:69651)
UniProt features (38 total): helix 11, strand 8, region of interest 5, turn 4, binding site 2, sequence conflict 2, chain 1, transmembrane region 1, disulfide bond 1, sequence variant 1, domain 1, short sequence motif 1
Structure
Experimental structures (PDB)
3 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2R4V | X-RAY DIFFRACTION | 1.85 |
| 2R5G | X-RAY DIFFRACTION | 1.86 |
| 2PER | X-RAY DIFFRACTION | 2 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O15247-F1 | 93.28 | 0.85 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (2): 227; 25
Disulfide bonds (1): 30–33
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-2672351 | Stimuli-sensing channels |
| R-HSA-5578775 | Ion homeostasis |
MSigDB gene sets: 285 (showing top):
WALLACE_PROSTATE_CANCER_RACE_UP, GOBP_CIRCULATORY_SYSTEM_PROCESS, GOBP_INORGANIC_ANION_TRANSPORT, GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_REGULATION_OF_THE_RELEASE_OF_SEQUESTERED_CALCIUM_ION, GOMF_GLUTATHIONE_TRANSFERASE_ACTIVITY, GOBP_MONOATOMIC_CATION_TRANSPORT, GNF2_ANK1, YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN, GOBP_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION, GOBP_REGULATION_OF_MUSCLE_CONTRACTION, GOBP_CHLORIDE_TRANSPORT, GOBP_MUSCLE_CONTRACTION, RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP, GOBP_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT, GOBP_CELLULAR_RESPONSE_TO_TOXIC_SUBSTANCE
GO Biological Process (9): chloride transport (GO:0006821), signal transduction (GO:0007165), regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880), regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881), monoatomic ion transport (GO:0006811), monoatomic ion transmembrane transport (GO:0034220), negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315), cellular oxidant detoxification (GO:0098869), chloride transmembrane transport (GO:1902476)
GO Molecular Function (4): glutathione peroxidase activity (GO:0004602), chloride channel activity (GO:0005254), protein binding (GO:0005515), oxidoreductase activity (GO:0016491)
GO Cellular Component (8): nucleus (GO:0005634), nucleoplasm (GO:0005654), cytoplasm (GO:0005737), cytosol (GO:0005829), plasma membrane (GO:0005886), membrane (GO:0016020), chloride channel complex (GO:0034707), monoatomic ion channel complex (GO:0034702)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Ion channel transport | 1 |
| Cardiac conduction | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| monoatomic anion transport | 1 |
| inorganic anion transport | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1 |
| regulation of release of sequestered calcium ion into cytosol | 1 |
| regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1 |
| regulation of cardiac muscle contraction by calcium ion signaling | 1 |
| transport | 1 |
| monoatomic ion transport | 1 |
| transmembrane transport | 1 |
| ryanodine-sensitive calcium-release channel activity | 1 |
| negative regulation of release of sequestered calcium ion into cytosol | 1 |
| regulation of ryanodine-sensitive calcium-release channel activity | 1 |
| negative regulation of calcium ion transmembrane transporter activity | 1 |
| cellular detoxification | 1 |
| chloride transport | 1 |
| monoatomic anion transmembrane transport | 1 |
| peroxidase activity | 1 |
| monoatomic anion channel activity | 1 |
| chloride transmembrane transporter activity | 1 |
| binding | 1 |
| catalytic activity | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
| membrane | 1 |
| cell periphery | 1 |
| monoatomic ion channel complex | 1 |
| transmembrane transporter complex | 1 |
Protein interactions and networks
STRING
882 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CLIC2 | MAPK15 | Q8TD08 | 828 |
| CLIC2 | PHC3 | Q8NDX5 | 749 |
| CLIC2 | TRDN | Q13061 | 557 |
| CLIC2 | RAB39B | Q96DA2 | 520 |
| CLIC2 | ASPH | Q12797 | 474 |
| CLIC2 | TRAK2 | O60296 | 473 |
| CLIC2 | EZR | P15311 | 458 |
| CLIC2 | PIN4 | Q9Y237 | 444 |
| CLIC2 | CAV1 | Q03135 | 437 |
| CLIC2 | RYR2 | Q92736 | 431 |
| CLIC2 | MT-CO1 | P00395 | 423 |
| CLIC2 | TMLHE | Q9NVH6 | 420 |
| CLIC2 | FAM229B | Q4G0N7 | 420 |
| CLIC2 | FUNDC2 | Q9BWH2 | 420 |
| CLIC2 | VBP1 | P61758 | 419 |
IntAct
15 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CLIC2 | TPRN | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLIC4 | CLIC2 | psi-mi:“MI:0914”(association) | 0.530 |
| CLIC5 | CLIC2 | psi-mi:“MI:0914”(association) | 0.350 |
| C15orf40 | CLIC2 | psi-mi:“MI:0914”(association) | 0.350 |
| RPL35 | CLIC2 | psi-mi:“MI:0914”(association) | 0.350 |
| RPP14 | CLIC2 | psi-mi:“MI:0914”(association) | 0.350 |
| TXNDC17 | CLIC2 | psi-mi:“MI:0914”(association) | 0.350 |
| SAP30 | CLIC2 | psi-mi:“MI:0914”(association) | 0.350 |
| CLIC2 | TPRN | psi-mi:“MI:0914”(association) | 0.350 |
| FN1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| CLIC2 | TPRN | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (25): CLIC2 (Affinity Capture-MS), CLIC2 (Affinity Capture-MS), CLIC2 (Affinity Capture-MS), CLIC2 (Affinity Capture-MS), CLIC2 (Two-hybrid), TPRN (Two-hybrid), CLIC2 (Affinity Capture-MS), TPRN (Affinity Capture-MS), CLIC2 (Affinity Capture-MS), SBDS (Affinity Capture-MS), CLIC2 (Affinity Capture-MS), CLIC2 (Affinity Capture-MS), CLIC2 (Affinity Capture-MS), CLIC2 (Affinity Capture-MS), CLIC2 (Affinity Capture-MS)
ESM2 similar proteins: A0A1L5BUX8, A0A1U8QXK4, A0A1U9YI21, B5BP46, C8VQ63, D4Z909, M1W426, O00299, O04487, O15247, O45405, O74830, P12261, P21161, P26642, P30111, P34345, P36008, P40921, P42936, P43387, Q00717, Q4WB03, Q5E9B7, Q5M883, Q5R957, Q5Z627, Q6MG61, Q6NMS0, Q6YW46, Q8BXK9, Q8WQA4, Q91375, Q95MF9, Q9CA57, Q9CAS6, Q9EPT8, Q9FUM1, Q9FUS6, Q9FUT0
Diamond homologs: O00299, O15247, O95833, P35526, Q29238, Q5E9B7, Q5M883, Q5R957, Q6MG61, Q811Q2, Q8BHB9, Q8BXK9, Q95MF9, Q96NY7, Q9D7P7, Q9EPT8, Q9N2G5, Q9NZA1, Q9QYB1, Q9XSA7, Q9Y696, Q9Z0W7, Q9Z1Q5, O45405, Q9VY78, P81124, Q9FRL8, Q8WQA4
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| ZNF804A | “down-regulates quantity by repression” | CLIC2 | “transcriptional regulation” |
Disease & clinical
Clinical variants and AI predictions
ClinVar
95 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 37 |
| Likely benign | 8 |
| Benign | 6 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1808688 | GRCh37/hg19 Xq28(chrX:154502832-154633634)x4 | Likely pathogenic |
SpliceAI
589 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:155278060:GCAAC:G | acceptor_gain | 1.0000 |
| X:155278061:CAAC:C | acceptor_gain | 1.0000 |
| X:155278061:CAACC:C | acceptor_gain | 1.0000 |
| X:155278062:AAC:A | acceptor_gain | 1.0000 |
| X:155278063:AC:A | acceptor_gain | 1.0000 |
| X:155278064:CC:C | acceptor_gain | 1.0000 |
| X:155278064:CCTA:C | acceptor_loss | 1.0000 |
| X:155278065:C:CA | acceptor_loss | 1.0000 |
| X:155278065:C:CC | acceptor_gain | 1.0000 |
| X:155278070:A:AC | acceptor_gain | 1.0000 |
| X:155278071:T:C | acceptor_gain | 1.0000 |
| X:155278071:T:TC | acceptor_gain | 1.0000 |
| X:155278072:T:C | acceptor_gain | 1.0000 |
| X:155278072:T:TC | acceptor_gain | 1.0000 |
| X:155278073:T:C | acceptor_gain | 1.0000 |
| X:155278073:T:TC | acceptor_gain | 1.0000 |
| X:155278076:C:CT | acceptor_gain | 1.0000 |
| X:155278077:A:T | acceptor_gain | 1.0000 |
| X:155279145:TTAC:T | donor_loss | 1.0000 |
| X:155279147:A:AC | donor_gain | 1.0000 |
| X:155279147:ACT:A | donor_loss | 1.0000 |
| X:155279148:C:CA | donor_gain | 1.0000 |
| X:155279148:CT:C | donor_gain | 1.0000 |
| X:155279148:CTT:C | donor_gain | 1.0000 |
| X:155279148:CTTT:C | donor_gain | 1.0000 |
| X:155279148:CTTTA:C | donor_gain | 1.0000 |
| X:155279326:AAAAT:A | acceptor_gain | 1.0000 |
| X:155279327:AAAT:A | acceptor_gain | 1.0000 |
| X:155279328:AAT:A | acceptor_gain | 1.0000 |
| X:155279329:AT:A | acceptor_gain | 1.0000 |
AlphaMissense
1637 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:155277972:A:C | F225L | 0.999 |
| X:155277972:A:T | F225L | 0.999 |
| X:155277974:A:G | F225L | 0.999 |
| X:155279162:A:G | L190P | 0.999 |
| X:155279179:A:C | C184W | 0.999 |
| X:155279181:A:G | C184R | 0.999 |
| X:155279294:A:G | L146P | 0.999 |
| X:155280002:A:C | F120L | 0.999 |
| X:155280002:A:T | F120L | 0.999 |
| X:155280003:A:G | F120S | 0.999 |
| X:155280004:A:G | F120L | 0.999 |
| X:155280011:A:C | F117L | 0.999 |
| X:155280011:A:T | F117L | 0.999 |
| X:155280012:A:C | F117C | 0.999 |
| X:155280013:A:G | F117L | 0.999 |
| X:155298809:A:G | L90S | 0.999 |
| X:155298862:G:C | F72L | 0.999 |
| X:155298862:G:T | F72L | 0.999 |
| X:155298864:A:G | F72L | 0.999 |
| X:155298866:G:T | P71Q | 0.999 |
| X:155298867:G:A | P71S | 0.999 |
| X:155299062:A:C | F47L | 0.999 |
| X:155299062:A:T | F47L | 0.999 |
| X:155299063:A:G | F47S | 0.999 |
| X:155299064:A:G | F47L | 0.999 |
| X:155299074:T:A | K43N | 0.999 |
| X:155299074:T:G | K43N | 0.999 |
| X:155299075:T:A | K43I | 0.999 |
| X:155299092:G:C | F37L | 0.999 |
| X:155299092:G:T | F37L | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000195252 (X:155275753 C>T), RS1000301853 (X:155285355 T>C), RS1000520478 (X:155310833 C>A), RS1000986289 (X:155328370 T>G), RS1001001769 (X:155319804 C>T), RS1001057917 (X:155310486 C>T), RS1001096762 (X:155319442 G>C,T), RS1001206498 (X:155306774 C>A), RS1001223601 (X:155292631 G>A,T), RS1001656943 (X:155323399 T>C), RS1001700165 (X:155306272 G>A), RS1001958712 (X:155323802 A>T), RS1002042885 (X:155334590 C>T), RS1002230923 (X:155293855 G>T), RS1002409743 (X:155282668 C>T)
Disease associations
OMIM: gene MIM:300138 | disease phenotypes: MIM:300886
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome | Moderate | X-linked |
| X-linked complex neurodevelopmental disorder | Disputed Evidence | X-linked |
ClinGen Gene-Disease Validity (1)
Expert-panel classifications — Definitive > Strong > Moderate > Limited > Disputed > Refuted.
| Disease | Classification | Inheritance |
|---|---|---|
| X-linked complex neurodevelopmental disorder | Disputed | XL |
Mondo (2): X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome (MONDO:0010473), X-linked complex neurodevelopmental disorder (MONDO:0100148)
Orphanet (1): X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome (Orphanet:324410)
HPO phenotypes
30 total (30 of 30 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000053 | Macroorchidism |
| HP:0000232 | Everted lower lip vermilion |
| HP:0000280 | Coarse facial features |
| HP:0000303 | Mandibular prognathia |
| HP:0000319 | Smooth philtrum |
| HP:0000396 | Overfolded helix |
| HP:0000400 | Macrotia |
| HP:0000414 | Bulbous nose |
| HP:0000426 | Prominent nasal bridge |
| HP:0001172 | Abnormal thumb morphology |
| HP:0001250 | Seizure |
| HP:0001263 | Global developmental delay |
| HP:0001344 | Absent speech |
| HP:0001634 | Mitral valve prolapse |
| HP:0001635 | Congestive heart failure |
| HP:0001640 | Cardiomegaly |
| HP:0001650 | Aortic valve stenosis |
| HP:0001653 | Mitral regurgitation |
| HP:0002187 | Profound intellectual disability |
| HP:0002465 | Poor speech |
| HP:0002510 | Spastic tetraplegia |
| HP:0002540 | Inability to walk |
| HP:0002751 | Kyphoscoliosis |
| HP:0003376 | Steppage gait |
| HP:0004749 | Atrial flutter |
| HP:0005180 | Tricuspid regurgitation |
| HP:0005280 | Depressed nasal bridge |
| HP:0005781 | Contractures of the large joints |
| HP:0006705 | Abnormal atrioventricular valve morphology |
| HP:0010808 | Protruding tongue |
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
26 total (human), top 26 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases methylation, increases expression | 3 |
| bisphenol A | decreases expression, increases expression | 2 |
| Arsenic Trioxide | increases expression | 2 |
| 2,5,2’,5’-tetrachlorobiphenyl | decreases expression | 1 |
| decabromobiphenyl ether | decreases expression | 1 |
| tetrabromobisphenol A | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | decreases expression | 1 |
| pentabrominated diphenyl ether 100 | increases expression | 1 |
| hexabrominated diphenyl ether 153 | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Demecolcine | increases expression | 1 |
| Estradiol | affects cotreatment, decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Progesterone | affects cotreatment, decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Smoke | decreases expression, increases abundance | 1 |
| Vincristine | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | affects expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_YA41 | IDG-HEK293T-CLIC2-V5-OE | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome, X-linked complex neurodevelopmental disorder
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): X-linked complex neurodevelopmental disorder, X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome